Keywords: cerepro, ph, iii, trial, gets, dsmb, go

Cerepro Ph III trial gets DSMB go ahead

Article | 15 January 2007

Print This

UK-based health care group Ark Therapeutics says that the observed side effect profile in a Phase III trial of its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in